Prevalence of abnormal pap smears in the western region of Saudi Arabia from 2010 to 2022.

IF 2.5 4区医学 Q2 PATHOLOGY

Cytojournal Pub Date : 2023-11-23 eCollection Date: 2023-01-01 DOI:10.25259/Cytojournal_17_2023

Abdulbasit A Andijany, Daliah A Abdulhafeez, Rehab B Fadag, Abdullah M Al Harbi, Rasha A Alsahafi, Elham S Bin Abbas, Walaa A Felemban

{"title":"Prevalence of abnormal pap smears in the western region of Saudi Arabia from 2010 to 2022.","authors":"Abdulbasit A Andijany, Daliah A Abdulhafeez, Rehab B Fadag, Abdullah M Al Harbi, Rasha A Alsahafi, Elham S Bin Abbas, Walaa A Felemban","doi":"10.25259/Cytojournal_17_2023","DOIUrl":null,"url":null,"abstract":"Objectives: The objectives of the study were to assess the prevalence of abnormal Pap smears and their quality metrics in a tertiary health-care facility in the western region of Saudi Arabia and to share our data with other researchers in Saudi Arabia to potentially establish benchmark data based on a Saudi population.Material and methods: A retrospective study was carried out by the Department of Pathology at King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia, on Pap smear statistics for 14,376 Pap smears of both conventional and liquid-based cytology (LBC) between 2010 and 2022.Results: The prevalence of abnormal Pap smears of both conventional and LBC was 3.05% (438 Pap smears). The percentages of adenocarcinoma and squamous cell carcinoma were 0.08% and 0.02%, respectively, and the ratio of atypical squamous cells (ASCs) to squamous intraepithelial lesions (SILs) (ASC/SIL) was 2.61.Conclusion: The prevalence of abnormal Pap smears and the ASC/SIL ratio were consistent with the international benchmark data provided by the College of American Pathologists for each preparation type and within the range of the data provided by published studies, highlighting the need for greater focus on glandular abnormalities.","PeriodicalId":49082,"journal":{"name":"Cytojournal","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695349/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cytojournal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.25259/Cytojournal_17_2023","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PATHOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: The objectives of the study were to assess the prevalence of abnormal Pap smears and their quality metrics in a tertiary health-care facility in the western region of Saudi Arabia and to share our data with other researchers in Saudi Arabia to potentially establish benchmark data based on a Saudi population.

Material and methods: A retrospective study was carried out by the Department of Pathology at King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia, on Pap smear statistics for 14,376 Pap smears of both conventional and liquid-based cytology (LBC) between 2010 and 2022.

Results: The prevalence of abnormal Pap smears of both conventional and LBC was 3.05% (438 Pap smears). The percentages of adenocarcinoma and squamous cell carcinoma were 0.08% and 0.02%, respectively, and the ratio of atypical squamous cells (ASCs) to squamous intraepithelial lesions (SILs) (ASC/SIL) was 2.61.

Conclusion: The prevalence of abnormal Pap smears and the ASC/SIL ratio were consistent with the international benchmark data provided by the College of American Pathologists for each preparation type and within the range of the data provided by published studies, highlighting the need for greater focus on glandular abnormalities.

查看原文本刊更多论文

2010 年至 2022 年沙特阿拉伯西部地区子宫颈抹片检查异常的流行率。

研究目的本研究的目的是评估沙特阿拉伯西部地区一家三级医疗机构中巴氏涂片异常的发生率及其质量指标，并与沙特阿拉伯的其他研究人员分享我们的数据，以建立基于沙特人口的基准数据：沙特阿拉伯吉达法赫德国王武装部队医院病理科对2010年至2022年期间14376例传统和液基细胞学（LBC）巴氏涂片统计数据进行了回顾性研究：结果：常规和液基细胞学巴氏涂片的异常发生率均为 3.05%（438 例）。腺癌和鳞癌的比例分别为 0.08% 和 0.02%，非典型鳞状细胞（ASC）与鳞状上皮内病变（SIL）的比例（ASC/SIL）为 2.61：巴氏涂片异常的发生率和 ASC/SIL 比率与美国病理学家学会为每种制备类型提供的国际基准数据一致，也在已发表研究提供的数据范围内，这突出表明需要更加关注腺体异常。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cytojournal PATHOLOGY-

CiteScore

2.20

自引率

42.10%

发文量

审稿时长

>12 weeks

期刊介绍： The CytoJournal is an open-access peer-reviewed journal committed to publishing high-quality articles in the field of Diagnostic Cytopathology including Molecular aspects. The journal is owned by the Cytopathology Foundation and published by the Scientific Scholar.